Veritas In Silico's RNA Function Control Patent Gains European Recognition

MT Newswires Live

2024/12/30

Veritas In Silico (TYO:130A) said its patent on its method for screening compounds for controlling RNA function, will be listed in the European Patent Bulletin on Jan. 1, 2025, according to its filing on Monday.

Originally registered in Japan in September 2020, this patent enhances the company's mRNA-targeted drug discovery technology.

Although it will have minimal immediate impact on business performance, the patent is crucial for Veritas In Silico's globalization and advancement of their ibVIS(r) drug discovery platform.

Veritas In Silico's shares jumped over 20%.

Price (JPY): $882.00, Change: $+150, Percent Change: +20.49%

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2495851986"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2495851986\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2495851986?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-30 17:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2495851986","market":"sh","top_or_hot":-1,"title":"Veritas In Silico's RNA Function Control Patent Gains European Recognition","media":"MT Newswires Live","content":"<html><body><p> Veritas In Silico (TYO:130A) said its patent on its method for screening compounds for controlling RNA function, will be listed in the European Patent Bulletin on Jan. 1, 2025, according to its filing on Monday.</p><p>Originally registered in Japan in September 2020, this patent enhances the company's mRNA-targeted drug discovery technology.</p><p>Although it will have minimal immediate impact on business performance, the patent is crucial for Veritas In Silico's globalization and advancement of their ibVIS(r) drug discovery platform.</p><p>Veritas In Silico's shares jumped over 20%.</p><p>Price (JPY): $882.00, Change: $+150, Percent Change: +20.49%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Veritas In Silico's RNA Function Control Patent Gains European Recognition</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVeritas In Silico's RNA Function Control Patent Gains European Recognition\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2024-12-30 17:53</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Veritas In Silico (TYO:130A) said its patent on its method for screening compounds for controlling RNA function, will be listed in the European Patent Bulletin on Jan. 1, 2025, according to its filing on Monday.</p><p>Originally registered in Japan in September 2020, this patent enhances the company's mRNA-targeted drug discovery technology.</p><p>Although it will have minimal immediate impact on business performance, the patent is crucial for Veritas In Silico's globalization and advancement of their ibVIS(r) drug discovery platform.</p><p>Veritas In Silico's shares jumped over 20%.</p><p>Price (JPY): $882.00, Change: $+150, Percent Change: +20.49%</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2495851986","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2495851986","pubTimestamp":1735552427,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Veritas In Silico (TYO:130A) said its patent on its method for screening compounds for controlling RNA function, will be listed in the European Patent Bulletin on Jan. 1, 2025, according to its filing","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK4585":"ETF&股票定投概念","BK4505":"高瓴资本持仓","BK4139":"生物科技","RNA":"Avidity Biosciences, Inc."},"translate_title":"Veritas In Silico的RNA功能控制专利获得欧洲认可","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RNA":1},"content_text":"Veritas In Silico (TYO:130A) said its patent on its method for screening compounds for controlling RNA function, will be listed in the European Patent Bulletin on Jan. 1, 2025, according to its filing on Monday.Originally registered in Japan in September 2020, this patent enhances the company's mRNA-targeted drug discovery technology.Although it will have minimal immediate impact on business performance, the patent is crucial for Veritas In Silico's globalization and advancement of their ibVIS(r) drug discovery platform.Veritas In Silico's shares jumped over 20%.Price (JPY): $882.00, Change: $+150, Percent Change: +20.49%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}